EANM procedural guidelines for radionuclide myocardial perfusion imaging with SPECT and SPECT/CT: 2015 revision

Since the publication of the European Association of Nuclear Medicine (EANM) procedural guidelines for radionuclide myocardial perfusion imaging (MPI) in 2005, many small and some larger steps of progress have been made, improving MPI procedures. In this paper, the major changes from the updated 201...

ver descrição completa

Detalhes bibliográficos
Autores: Verberne, HJ, Acampa, W, Anagnostopoulos, C, Ballinger, J, Bengel, F, De Bondt, P, Buechel, RR, Cuocolo, A, van Eck-Smit, BLF, Flotats, A, Hacker, M, Hindorf, C, Kaufmann, PA, Lindner, O, Ljungberg, M, Lonsdale, M, Manrique, A, Minarik, D, Scholte, AJHA, Slart, RHJA, Tragardh, E, de Wit, TC, Hesse, B
Formato: artículo
Estado:Versión publicada
Fecha de publicación:2015
País:España
Recursos:Institut d’Investigació Biomèdica Sant Pau (IIB Sant Pau)
Repositorio:r-IIB SANT PAU. Repositorio Institucional de Producción Científica del Instituto de Investigación Biomédica Sant Pau
OAI Identifier:oai:iibsantpau.fundanetsuite.com:p7881
Acesso em linha:https://iibsantpau.fundanetsuite.com/Publicaciones/ProdCientif/PublicacionFrw.aspx?id=7881
http://ddd.uab.cat/record/185403
Access Level:acceso abierto
Palavra-chave:Guidelines
Myocardial perfusion imaging
Nuclear medicine
Procedures
Descrição
Resumo:Since the publication of the European Association of Nuclear Medicine (EANM) procedural guidelines for radionuclide myocardial perfusion imaging (MPI) in 2005, many small and some larger steps of progress have been made, improving MPI procedures. In this paper, the major changes from the updated 2015 procedural guidelines are highlighted, focusing on the important changes related to new instrumentation with improved image information and the possibility to reduce radiation exposure, which is further discussed in relation to the recent developments of new International Commission on Radiological Protection (ICRP) models. Introduction of the selective coronary vasodilator regadenoson and the use of coronary CT-contrast agents for hybrid imaging with SPECT/CT angiography are other important areas for nuclear cardiology that were not included in the previous guidelines.

Registos relacionados